Dr. David L. Groteluschen, MD
- Medicare services, 2024
- 557
- Medicare patients, 2024
- 222
- Part D claims, 2024
- 1,333
- Publications
- 5
- MIPS score, 2024
- 100
- Practice address
- 135 S Gibson St, Medford, WI 54451
- Practice phone
- Call (715) 748-8100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Groteluschen's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David L. Groteluschen is a medical oncologist in Medford, Wisconsin
Dr. Groteluschen practices at Aspirus Medford Hospital in Medford, Wisconsin, part of Aspirus.
Dr. Groteluschen's NPI, 1679538011, was assigned on April 19, 2006. Dr. Groteluschen graduated from University of Iowa, RJ & L Carver College of Medicine in 2001. Dr. Groteluschen holds Wisconsin license 44953.
- NPI
- 1679538011NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3971516519
- NPI enumeration date
- April 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (715) 748-8100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David L. Groteluschen practices at Aspirus Medford Hospital in Medford, Wisconsin
Dr. Groteluschen's primary practice is Aspirus Medford Hospital, at 135 S Gibson St, Medford, WI 54451 in Taylor County. The practice phone is (715) 748-8100.
- Aspirus Medford Hospital135 S Gibson St, Medford, WI 54451 · Taylor CountyPhone(715) 748-8100
Source: Dmand AI Affiliation Data
Dr. David L. Groteluschen is affiliated with 7 sites of care and 4 medical groups
Dr. Groteluschen's primary practice is Aspirus Medford Hospital in Medford, Wisconsin, part of Aspirus. Dr. Groteluschen is also affiliated with HSHS St. Vincent Hospital. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Groteluschen to 4 more hospitals, 3 medical groups and 1 hospice, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. David L. Groteluschen's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Groteluschen practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Aspirus Medford Hospital | Available with a free account |
| +6 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Aspirus and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David L. Groteluschen is one of 73 medical oncologists in Wisconsin
Medical oncology is Dr. Groteluschen's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Groteluschen is licensed in Wisconsin.
Specialties and state licenses
- Medical oncology, WisconsinPrimary
Medical oncologists near Dr. Groteluschen
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David L. Groteluschen billed Medicare for 557 services in 2024
CMS data shows 557 Medicare services from Dr. Groteluschen across 6 procedure codes in 2024, for 222 Medicare patients. Medicare paid $48,337 for them.
Dr. Groteluschen's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4742024: 473No change
- Other services
- 2023: 02024: 84
Where Dr. Groteluschen's Medicare services took place, 2024
- In an office48587%
- In a facility7213%
Dr. Groteluschen compared with the Wisconsin median for medical oncologists, 2024
- Dr. Groteluschen
- Wisconsin median
- Medicare services
- 557vs 32273% above
- Medicare patients
- 222vs 12479% above
- Part D claims
- 1,032vs 2214.7 times
Medians across 70 medical oncologists in Wisconsin with Dmand AI profiles that report each measure.
Dr. Groteluschen's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Groteluschen?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Groteluschen and other medical oncologists in Wisconsin.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David L. Groteluschen treated 222 Medicare patients in 2024, average age 74
CMS counts 222 Medicare patients who saw Dr. Groteluschen in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Groteluschen's median patient age at 72, with 51% women.
Dr. Groteluschen's Medicare patients by age, 2024
Dr. Groteluschen's Medicare patients by sex, 2024
- Women11853%
- Men10447%
Chronic conditions among Dr. Groteluschen's Medicare patients, 2024
- High blood pressure75%
- High cholesterol68%
- Cancer49%
- Arthritis40%
- Ischemic heart disease38%
- Anxiety33%
- Chronic kidney disease32%
- Diabetes28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Groteluschen's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women51%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David L. Groteluschen wrote 1,333 Medicare Part D claims in 2024
In 2024, Dr. Groteluschen wrote 1,333 Medicare Part D claims for 314 patients. 75% of them were for generic drugs. CMS names the drug for 1,032 of them, across 38 drugs with 11 or more claims each, at $3,012,303 in total drug cost. In 2023, CMS named 732 claims across 29 drugs.
Dr. Groteluschen's Part D claims by kind of drug, 2024
- Generic998 claims75%
- Brand-name335 claims25%
Dr. Groteluschen's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Groteluschen's Part D claims, 2024
- Opioids9%119 of 1,333 claims
- Antibiotics5%64 of 1,333 claims
- Antipsychotics, patients 65 and over1%19 of 1,333 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7322024: 1,03241%
Drugs named by CMS: 38 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. David L. Groteluschen scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Groteluschen for performance year 2024, reported as part of a group. Dr. Groteluschen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Groteluschen's MIPS scores, performance year 2024
- 100of 100Final score
- 97.2of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David L. Groteluschen has 5 publications on record
Dmand AI links 5 papers to Dr. Groteluschen, published from 2012 to 2017. 2012 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Capecitabine and Deoxycytidine. Dr. Groteluschen's most frequent co-authors are Sam Joseph Lubner, MD, Daniel L. Mulkerin, MD and Ernie Porteza Balcueva, MD.
Dr. Groteluschen's papers by year, 2012 to 2017
Topics Dr. Groteluschen writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Capecitabine
- Deoxycytidine
- Fluorouracil
- Niacinamide
- Organoplatinum Compounds
- Pancreatic Neoplasms
- Phenylurea Compounds
Dr. Groteluschen's most frequent co-authors
- Sam Joseph Lubner, MD2 shared papers
- Daniel L. Mulkerin, MD2 shared papers
- Ernie Porteza Balcueva, MD1 shared paper
Recent publications by Dr. Groteluschen
Clin Genitourin Cancer
Cancer Chemother Pharmacol
See who Dr. Groteluschen researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Groteluschen works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David L. Groteluschen received $46 in industry payments from 2018 to 2023
CMS Open Payments shows 3 general payments to Dr. Groteluschen from 3 drug and device companies from 2018 to 2023. Education make up the largest share, 69% of the total. Merck Sharp & Dohme Corporation paid the most, $20.
General payments to Dr. Groteluschen by program year, 2018 to 2023
General payments to Dr. Groteluschen by kind, 2018 to 2023
- Education$3269%
- Food and beverage$1431%
Companies that paid Dr. Groteluschen the most, 2018 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David L. Groteluschen graduated from University of Iowa, RJ & L Carver College of Medicine
Dr. Groteluschen graduated from University of Iowa, RJ & L Carver College of Medicine in 2001.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. David L. Groteluschen's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David L. Groteluschen
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David L. Groteluschen's NPI number?
Dr. David L. Groteluschen's NPI number is 1679538011. It was assigned on April 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David L. Groteluschen?
Dr. David L. Groteluschen is a medical oncologist in Medford, Wisconsin. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. David L. Groteluschen practice?
Dr. Groteluschen practices at 135 S Gibson St, Medford, WI 54451. Dr. Groteluschen's primary practice is Aspirus Medford Hospital in Medford, Wisconsin, part of Aspirus. Dmand AI also links Dr. Groteluschen to 4 hospitals, 3 medical groups and 1 hospice.
What is Dr. David L. Groteluschen's office phone number?
The practice phone on file for Dr. Groteluschen is (715) 748-8100.
What is Dr. David L. Groteluschen's medical license number?
Dr. Groteluschen holds Wisconsin license 44953.
Which hospitals is Dr. David L. Groteluschen affiliated with?
Dr. Groteluschen practices at Aspirus Medford Hospital in Medford, Wisconsin. Dr. Groteluschen is also affiliated with HSHS St. Vincent Hospital. Dmand AI links Dr. Groteluschen to 4 more hospitals.
What medical group is Dr. David L. Groteluschen part of?
Dr. Groteluschen is linked to OSF Multi-Specialty Group. Dmand AI links Dr. Groteluschen to 3 more medical groups.
Does Dr. David L. Groteluschen accept Medicare?
Yes. CMS data shows Dr. Groteluschen billed Medicare for 557 services in 2024, and Dr. Groteluschen accepts Medicare assignment.
What is Dr. David L. Groteluschen's MIPS score?
Dr. Groteluschen's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
How many Medicare patients does Dr. David L. Groteluschen see?
CMS counts 222 Medicare patients who saw Dr. Groteluschen in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. David L. Groteluschen bill to Medicare?
In 2024, Dr. Groteluschen's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and medicare service (G2211).
Where did Dr. David L. Groteluschen go to medical school?
Dr. Groteluschen graduated from University of Iowa, RJ & L Carver College of Medicine in 2001.
What drugs does Dr. David L. Groteluschen prescribe most?
In 2024 Medicare Part D data, Dr. Groteluschen's most prescribed drugs by claims were Ondansetron HCl, Prednisone and Tamoxifen Citrate.
Has Dr. David L. Groteluschen received payments from drug or device companies?
CMS Open Payments shows $46 in general payments to Dr. Groteluschen from 3 companies from 2018 to 2023. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. David L. Groteluschen been practicing?
Dr. Groteluschen graduated from medical school in 2001, 25 years ago.
Does Dr. David L. Groteluschen do research?
Dmand AI links 5 publications to Dr. Groteluschen, published from 2012 to 2017.
Who does Dr. David L. Groteluschen publish with?
Dr. Groteluschen's most frequent co-authors are Sam Joseph Lubner, MD (2 shared papers), Daniel L. Mulkerin, MD (2 shared papers) and Ernie Porteza Balcueva, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Wisconsin by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card